CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Jae Hyun Bae, Sunhee Kim, Eun-Gee Park, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
Endocrinol Metab. 2019;34(1):80-92.   Published online March 21, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.1.80

Excel Download

Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis
Diabetes, Obesity and Metabolism. 2012;14(12):1061-1072   Crossref logo
Link1

Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Endocrinology and Metabolism. 2019;34(1):80   Crossref logo
Link1 Link2 Link3

Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitus
Diabetes Research and Clinical Practice. 2016;116:171-182   Crossref logo
Link1 Link2

Short-term and long-term effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with renal impairment: a meta-analysis of randomized controlled trials
Diabetes/Metabolism Research and Reviews. 2015;32(6):460-469   Crossref logo
Link1 Link2

Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis
Diabetes & Metabolism. 2017;43(1):1-8   Crossref logo
Link1 Link2

Dipeptidyl peptidase-4 inhibitors and risk of arthralgia: A systematic review and meta-analysis
Diabetes & Metabolism. 2017;43(6):493-500   Crossref logo
Link1 Link2

Renal outcomes with dipeptidyl peptidase-4 inhibitors
Diabetes & Metabolism. 2018;44(2):101-111   Crossref logo
Link1 Link2

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients with Moderate to Severe Renal Impairment: A Systematic Review and Meta-Analysis
PLoS ONE. 2014;9(10):e111543   Crossref logo
Link1

Effect of Dipeptidyl Peptidase-4 Inhibitors on Hemoglobin a1c In Patients with Type 2 Diabetes Mellitus and Renal Impairment: a Systematic Review and Meta-analysis
Value in Health. 2015;18(3):A55   Crossref logo
Link1 Link2

Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis
BMC Pharmacology and Toxicology. 2019;20(1):   Crossref logo
Link1 Link2 Link3